Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Meeting to be held in Chicago on January 23 and in the Midwest on January 24 hosted by Piper Sandler.Invest with Confidence: Follow TipRanks' ...

Phreesia (PHR) closed the last trading session at $23.84, gaining 25.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

January 17, 2025, 04:12 am ET, BY Momei- Contributor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) ...

Citi raised the firm’s price target on Phreesia (PHR) to $35 from $31 and keeps a Buy rating on the shares as part of a 2025 outcook for the ...

Phreesia, Inc. (NYSE:PHR – Get Free Report) has earned a consensus rating of “Buy” from the twelve brokerages that are covering the company, MarketBeat.com reports. Twelve analysts have rated the ...

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation ...

Phreesia (NYSE:PHR – Free Report) had its price objective raised by Citigroup from $31.00 to $35.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a buy ...

Chicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR. Link: ...

WILMINGTON, Del. (AP) — WILMINGTON, Del. (AP) — Phreesia Inc. (PHR) on Monday reported a loss of $14.4 million in its fiscal third quarter. On a per-share basis, the Wilmington, Delaware-based ...